Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvs    crawled date : 2022 - 04 - 25    save search

Ontario and Quebec become the first provinces to list Kesimpta (ofatumumab) for the treatment of adults with relapsing remitting multiple sclerosis (RRMS)
Published: 2022-04-25 (Crawled : 14:00) - biospace.com/
NVS | News | $98.17 3.21% 780K twitter stocktwits trandingview |
Health Technology
| | O: -0.67% H: 0.0% C: 0.0%

treatment sclerosis multiple sclerosis
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.75 6.33% 0 twitter stocktwits trandingview |
Health Technology
| | O: -2.78% H: 0.0% C: 0.0%
GLAXF | News | $20.305 630 twitter stocktwits trandingview |
Health Technology
| | O: -0.99% H: 0.0% C: -0.11%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 0.0% C: 0.0%
MNKKQ | $0.02 twitter stocktwits trandingview |
Manufacturing
| | O: -2.96% H: 2.29% C: -6.57%
ALPMY | News | $9.53 690K twitter stocktwits trandingview |
Manufacturing
| | O: -0.1% H: 0.35% C: -0.09%
VTRS | News A | $11.3 0.44% 570K twitter stocktwits trandingview |
Health Technology
| | O: -5.01% H: 0.0% C: 0.0%
NVS | News | $98.17 3.21% 780K twitter stocktwits trandingview |
Health Technology
| | O: -0.67% H: 0.0% C: 0.0%
JNJ | News | $148.88 -0.16% 940K twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.0% C: 0.0%
GSK | News | $40.795 0.51% 150K twitter stocktwits trandingview |
Health Technology
| | O: -1.57% H: 1.5% C: 1.39%
BSX | $68.27 0.37% 240K twitter stocktwits trandingview |
Health Technology
| | O: -4.95% H: 2.32% C: 1.9%
BHC | $8.485 0.41% 65K twitter stocktwits trandingview |
Health Technology
| | O: -3.12% H: 0.37% C: 0.19%
ABBV | News | $169.05 0.69% 66K twitter stocktwits trandingview |
Health Technology
| | O: -2.17% H: 0.0% C: 0.0%
SNY | News | $47.36 0.45% 120K twitter stocktwits trandingview |
Health Technology
| | O: -2.01% H: 0.0% C: 0.0%
NMRD | $0.072 43K twitter stocktwits trandingview |
Health Technology
| | O: 17.02% H: 0.52% C: -2.6%
AMGN | News | $273.97 0.76% 69K twitter stocktwits trandingview |
Health Technology
| | O: -1.38% H: 0.65% C: 0.46%

device disease
Hyperalgesia Drugs in Development Report 2022: Featuring Caventure Drug Discovery, Charleston Laboratories, Exodos Life Sciences and Novartis
Published: 2022-04-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $98.17 3.21% 780K twitter stocktwits trandingview |
Health Technology
| | O: -0.67% H: 0.0% C: 0.0%

drug report novartis
Gainers vs Losers
84% 16%

Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M twitter stocktwits trandingview |

AGBA | $2.615 109.2% 14M twitter stocktwits trandingview |
Finance

EDBL | News | $7.37 96.01% 650K twitter stocktwits trandingview |

PALI | $7.64 54.97% 14M twitter stocktwits trandingview |
Manufacturing

OPRT | News | $3.19 41.78% 3M twitter stocktwits trandingview |
Finance

PEGY | $0.0629 37.34% 110M twitter stocktwits trandingview |
Manufacturing

MLEC | $1.87 33.57% 1.6M twitter stocktwits trandingview |
n/a

ATGL | $3.66 27.97% 150K twitter stocktwits trandingview |

VNRX | $0.759 26.5% 390K twitter stocktwits trandingview |
Health Technology

SMFL | $5.35 22.99% 11M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.